Dr. Nilay V. Mehta, M.D.
Radiology (Diagnostic Radiology Physician)
1901 Medi Park Dr Ste 2050
Amarillo, TX 79106
Who else practices at this address →
Potter County includes primary care (100% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 14
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 2,228
Licensed in Texas since 2018, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Diagnostic Radiology Physician primary
TX license R5900 (first issued 2018; active) - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Bsa Hospital Amarillo, TX
- Glen Rose Medical Center Glen Rose, TX
- Lovelace Regional Hospital - Roswell Roswell, NM
- Childress Regional Medical Center Childress, TX
- Cogdell Memorial Hospital Snyder, TX
Medical groups
- High Plains Radiological Association LLP (35 clinicians)
- Open Air Imaging Center LLP (25 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 2,228
- Services billed
- 3,933
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| X-ray of chest, 2 views | 613 | 601 |
| X-ray of chest, 1 view | 231 | 219 |
| Ultrasound scan of head and neck soft tissue | 125 | 125 |
| X-ray of shoulder, minimum of 2 views | 105 | 98 |
| Ct scan of abdomen and pelvis without contrast | 91 | 90 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 83 | 77 |
| Ultrasonic guidance for blood vessel access | 78 | 55 |
| Ct scan head or brain without contrast | 75 | 75 |
| X-ray of abdomen, 2 views | 54 | 52 |
| X-ray of knee, 1-2 views | 50 | 46 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 9 companies reported 33 payments worth $1,194 in total to this clinician.
| Boston Scientific Corporation | $365 |
|---|---|
| Penumbra, Inc. | $349 |
| GE Healthcare | $161 |
| Siemens Medical Solutions USA, Inc. | $110 |
| Stryker Corporation | $85.56 |
| Sirtex Medical Inc | $38.85 |
| Trisalus Life Sciences, Inc. | $38.46 |
| Edwards Lifesciences Corporation | $29.13 |
| Food and Beverage | $1,194 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $109,984 in research payments for these studies, mostly to the institutions running them.
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
Eli Lilly and Company · Active, not recruiting · NCT06292013
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.